PANews reported on September 15th that decentralized science platform Bio Protocol announced a $7.1 million funding round led by Maelstrom Fund, with participation from Mechanism Capital, Animoca Brands, and Atria Ventures. This funding round coincided with the launch of Bio V2, which introduced on-chain fundraising, a decentralized AI research framework, and BioXP, an incentive system. BioAgents, decentralized scientific AI agents, support researchers and communities in generating hypotheses, funding experiments, and monetizing discoveries. The first BioAgent, launched in August in partnership with VitaDAO and Aubrey de Grey's lab, has generated over $250,000 in research funding and over a thousand longevity hypotheses.